Form 4: I-Mab Director Reports Stock Transaction
Insider Transaction (Form 4)
Ian Ying Woo, a Director of I-Mab, reported multiple transactions in common stock on October 15, 2026.
Summary
- Option exercise/conversion: acquired 13,271 Ordinary Shares on October 15, 2026; holds 13,271 after (Direct).
- Option exercise/conversion: disposed of 5,770 Restricted Share Units on October 15, 2026; holds 11,540 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ian Ying Woo — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Ordinary Shares | 13,271 | — | — | 13,271 |
| 2026-10-15 | Option exercise/conversion | Restricted Share Units | 5,770 | — | — | 11,540 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (13,271 shares) |
| 2026-10-15 | Option exercise/conversion (5,770 shares) |
Keywords
insider transaction, Form 4, NBP, NovaBridge Biosciences, neutral, Ian Ying Woo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.